Paragon 28
-
Extremities
Paragon 28 Launches the Phantom® Fibula Nail System for Less Invasive Fracture Repair
Phantom® Fibula Nail implanted in the fibula for fracture stabilization with syndesmotic repair using the R3FLEX™ Stabilization System ENGLEWOOD, Colo.,…
Read More » -
Extremities
Paragon 28 Introduces a Novel Right-Angle Drill for the APEX 3D™ Total Ankle Replacement System
ENGLEWOOD, Colo., September 10, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) is pleased to announce the addition of a novel Right-Angle…
Read More » -
Extremities
Paragon 28 Launches the R3FLEX™ Stabilization System to Anatomically Repair Ankle Syndesmotic Injuries
R3FLEX™ Stabilization System and Gorilla® Ankle Fracture Plating System used to treat an ankle fracture with syndesmotic injury. ENGLEWOOD, Colo.,…
Read More » -
Financial
Paragon 28 Appoints Chadi Chahine as Chief Financial Officer and Executive Vice-President of Supply Chain Operations, Reports Second Quarter 2024 Financial Results and Narrows 2024 Net Revenue Guidance
ENGLEWOOD, Colo., August 9, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Financial
Paragon 28 to Report Second Quarter 2024 Financial Results on August 8, 2024
ENGLEWOOD, Colo., July 17, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the…
Read More » -
Financial
Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
ENGLEWOOD, Colo., May 8, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Extremities
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
Stephen Deitsch resigns from his position as Chief Financial Officer to pursue another opportunity; Kristina Wright appointed interim Chief Financial…
Read More » -
Extremities
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
Figure 1: Anterior inferior tibiofibular ligament (“AITFL”) Repair Showing the Grappler® R3INFORCE™ Dynamic Anchor (left) and Grappler® Knotless Anchor (center).…
Read More » -
Extremities
Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions
ENGLEWOOD, Colo., February 1, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of the…
Read More » -
Extremities
Paragon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures
ENGLEWOOD, Colo., January 24, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA) is proud to announce a novel solution in…
Read More » -
Extremities
Paragon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer Procedures
Paragon 28 Mister Tendon™ Harvester and Blunt Dissection Probe ENGLEWOOD, Colo., January 26, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE:…
Read More » -
Extremities
Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures
ENGLEWOOD, Colo., January 17, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), is excited to announce the limited market release of its…
Read More » -
Financial
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023
ENGLEWOOD, Colo., January 8, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively…
Read More » -
Extremities
Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape
ENGLEWOOD, Co., January 5, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA), is thrilled to announce the launch of the…
Read More » -
Biologics
Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio
ENGLEWOOD, Colo., November 14, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its BEAST™ Cortical…
Read More »